Recombinant vaccinia virus: immunization against multiple pathogens.
about
Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virusEvidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia VirusExpression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVAPre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow feverNovel viral vectored vaccines for the prevention of influenza.Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion proteinImmunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus.Surface expression of viral glycoproteins is polarized in epithelial cells infected with recombinant vaccinia viral vectorsProduction of specific antibodies against protein A fusion proteinsVaccinia virus vectors: new strategies for producing recombinant vaccines.Vaccines with enhanced costimulation maintain high avidity memory CTL.Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants.NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory molecules.Enteric immunization of mice against influenza with recombinant vacciniaA tandemly-oriented late gene cluster within the vaccinia virus genomeRecombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunityImmunological principles and emerging strategies of vaccination for the elderly.Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination.Vaccinia virus recombinants expressing the SA11 rotavirus VP7 glycoprotein gene induce serotype-specific neutralizing antibodiesVaccinia virus: a tool for research and vaccine development.New therapeutic vaccination strategies for the treatment of chronic hepatitis B.Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector.Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system.Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice.Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells.Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants.Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity.M protein (M1) of influenza virus: antigenic analysis and intracellular localization with monoclonal antibodies.Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.Delivery and expression of a heterologous antigen on the surface of streptococci.Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck.Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection.Protective efficacy of a recombinant vaccinia virus in vaccinia-immune mice.Vaccinia virus-mediated damage of murine ovaries and protection by virus-expressed interleukin-2.A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses.
P2860
Q27486585-129C0C9B-1107-4395-9262-ADA084E09044Q27487131-763CCC9E-3C8C-4E59-AEA7-1FAE763ED7BCQ28727937-EA2B2FE5-DC64-4D93-8DD9-AE5ABC305D4BQ28740522-02CE8BCF-04C4-495E-9E1A-7852E6D8E35DQ30418570-BDA0C7F5-F4C8-476E-95F4-6F0523A502E4Q33554501-13A05BFF-F72F-4278-9A84-B2E23768705FQ33608668-42469FA4-FAB3-4806-8857-F6E0ECAA2436Q33879343-DA97ED9A-5110-458C-A2C5-1C893C9FF520Q33880423-9F38B7E5-769D-4A7E-9856-946BD88BEB8FQ34211635-64BE2913-3903-4772-BC43-8A6C1C03D0B0Q34312218-ED020AFB-E1EA-4302-A2D8-50BFEC2F6259Q35042482-F803BB8D-8CA4-4BE5-AA9A-35714251B02EQ35519418-6132CDB8-CA89-4A48-B1CA-182967B5AE90Q35847648-79476C3A-5875-4CB8-8201-28474773E4A8Q35900617-5D8B57A8-ACD3-4CFF-B6BF-BB53689F9908Q36095757-3A8FEC58-9279-4218-BE42-CC6C09E2BB46Q36679394-BA34CA0F-88F0-4F9F-BA84-5C773DF39C64Q36728309-D28ABA8E-BB9C-462D-A750-9B29C526DFF7Q36830970-59D4DD94-B6FD-467E-AAD8-E43BF81E61A3Q36866619-58854A81-A9E3-44C5-8F5F-524F4F98B0C3Q36886323-05B3ACAB-154C-47FE-B476-06B8A4C4B310Q37755852-1CE4C479-365C-438C-8FAC-98E55D97A28AQ38180981-C2CDEC37-F65C-45DB-BE03-144DA22B9536Q39592790-108069D1-A167-467B-9689-2619F4674B32Q39594611-B43CAA3C-07BD-48AE-9B76-6640A6B424C1Q39864202-FEC363F5-9E90-4392-898D-A7FE01C8A4FCQ40008615-45501A69-77F1-4B51-BA71-0554C30F9030Q40065736-4307CBBE-02AD-4164-955F-40A1286B777CQ40108953-837CE59E-9CFF-491A-8F37-3B6549CD4C7AQ40116675-23DF3026-382B-46B7-958B-898E6E85ADEEQ40116789-365F4832-19D5-4848-A859-1C762472E871Q40146546-BABF21BC-8D84-494B-9B4A-20A0B3B1A1B1Q41218508-CB8EFEA2-588B-44A3-9083-7E997007EC03Q41353633-9013B054-FDF5-4EBF-8B07-FCB604EE24C1Q45844152-BD41D358-461B-49F3-92B7-9BA1EEF4FDABQ45852461-60BE58D5-4E43-4507-825A-6A4817E1035EQ51336011-A7329B03-2CDD-440D-BD31-85A4DDB6E613
P2860
Recombinant vaccinia virus: immunization against multiple pathogens.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Recombinant vaccinia virus: immunization against multiple pathogens.
@en
Recombinant vaccinia virus: immunization against multiple pathogens.
@nl
type
label
Recombinant vaccinia virus: immunization against multiple pathogens.
@en
Recombinant vaccinia virus: immunization against multiple pathogens.
@nl
prefLabel
Recombinant vaccinia virus: immunization against multiple pathogens.
@en
Recombinant vaccinia virus: immunization against multiple pathogens.
@nl
P2093
P356
P1433
P1476
Recombinant vaccinia virus: immunization against multiple pathogens.
@en
P2093
Lipinskas BR
Paoletti E
P304
P356
10.1126/SCIENCE.2992092
P407
P577
1985-09-01T00:00:00Z